Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Assistance Publique - Hôpitaux de Paris
AbbVie
Diakonhjemmet Hospital
Virtual Tribunal Monastery
University of Aarhus